Citadel Advisors »

Ascentage Pharma Group Intl shares owned by Citadel Advisors

Quarter-by-quarter ownership of Ascentage Pharma Group Intl (AAPG) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Ascentage Pharma Group Intl

Tip: Access up to 7 years of quarterly data

All positions including Ascentage Pharma Group Intl held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascentage Pharma Group Intl by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $383k 9.7k 39.69

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Ascentage Pharma Group Intl

UBS Group
XY Capital
Point72
Tema Etfs
NEOS Investment Management
Citadel Advisors
Abc Arbitrage Sa
Mirae Asset Global Investments
Morgan Stanley
Tower Research Capital
Advisor Group Holdings
EverSource Wealth Advisors
Bell Investment Advisors

View all funds holding Ascentage Pharma Group Intl